Looks like our strains will have multiple uses over several multi billion dollar market products.
Just cheap and still buying.
From the quarterly:
"When compared to market leader, Aricept, which is currently used in the early management of Alzheimer’sDisease, the Dolce/NTI strains demonstrated 30% more potency than Aricept (and 80% more potency than CBD alone). Aricept currently has annual sales of over $1 billion USD and is the leading therapy in the early treatment of AD."
Cheers
Looks like our strains will have multiple uses over several...
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 6584 | 3 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable